1 minute read
Hyundai Hope on Wheels
Grants CONTINUED
Hyundai Hope on Wheels Rolls in Grant for New Pediatric Cancer Treatment
As the home of the Beat Childhood Cancer Research Consortium, Levine Children’s Hospital is developing promising therapies for high-risk and rare forms of pediatric cancer. Under the leadership of Dr. Giselle Saulnier Sholler, the consortium offers a worldwide network of Phase I and Phase II clinical trials, giving patient families hope when standard treatments have failed.
With a $300,000 grant from Hyundai Hope on Wheels, Dr. Sholler and Dr. Jeffrey Huo will research a new potential treatment for two non-medulloblastoma pediatric brain tumors – Atypical Teratoid Rhabdoid Tumors (ATRT) and Embryonal Tumors with Multilayered Rosettes (ETMR) – both of which have dismal prognoses with current therapies.
Grant funds will be used to conduct a two-year study, the findings of which may have rapid, significant, and broader long-term impacts on children with other types of hard-to-treat tumors.
1
2 1. Dr. Giselle Sholler (pictured), chair of the Beat Childhood Cancer Research Consortium and director of the Isabella Santos Foundation Rare & Solid Tumor Program at Atrium Health Levine Children’s, and Dr. Jeffrey Huo, attending physician, Pediatric Stem Cell Transplant & Cellular Therapies at Atrium Health Levine Children’s, hope to advance neuroblastoma research with support from Hyundai Hope on Wheels and other philanthropic gifts.
